Free tracked shipping
LYZE LABS
Lyze Labs Survodutide 5 mg kit - Research Use Only
GLP-1 and metabolic

Survodutide

Survodutide (BI 456906) is Boehringer Ingelheim's GLP-1 and glucagon dual agonist. Each kit is 10 vials from one batch, 5, 10 or 15 mg a vial.

10 vials from one batchFreeze-dried powder4.8 on Trustpilot

Also known as BI 456906

For research and laboratory use only. Not for human consumption.

$295a kit

Strength per vial
Choose how many kits

Mix any kits. Every kit in your cart counts toward the price. More than 50, or a custom size? Ask for a quote

1
Batch
Delivery
Free tracked shipping to 150+ countries. Delivery guaranteed. How delivery works
Report
Batch report after the first test · Delivery photos
Guarantee
Once this compound's first Certificate of Analysis is published at /lab-results, the same below-COA-purity reship guarantee applies.
Help
A person answers on WhatsApp, even at 3 a.m. your time.

Survodutide: Key Facts

Survodutide is a weight loss research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 3 formats. Batch certificates of analysis are published on the lab-results page as verification completes.

CompoundSurvodutide
Research categoryGLP-1 and metabolic
Available formats5mg*10vials, 10mg*10vials, 15mg*10vials
Strength shown5 mg
Molecular formulaC₁₉₂H₂₈₉N₄₇O₆₁
Molecular weight4232 g/mol
CAS number2805997-46-8
PurityPublished on the lab-results page as verification completes
Test methodHPLC + mass spectrometry
Certificate of analysisPublished on the lab-results page after the first test
Intended useLaboratory research use only. Not for human consumption.
HandlingSupplied lyophilized, store per the stability guide

Good to know

All ten vials are from one batch. One batch report covers the whole kit, so the first vial matches the last.

Your price drops with every kit. Any mix counts, up to 42% off at 50 kits.

About This Product

What is survodutide?

Survodutide is a lab-made peptide that acts on two receptors at once. GLP-1 lowers appetite. Glucagon raises energy use and works on the liver. Boehringer Ingelheim makes it, under the code BI 456906.

Because of its glucagon side, it is studied as much for fatty liver disease (MASH) as for weight.

How does survodutide work?

  • GLP-1 receptor: less hunger and slower stomach emptying.
  • Glucagon receptor: more energy use and more fat burned in the liver.
  • Weekly: it stays active for days, so the trials gave it once a week.

What do researchers study it for?

  • Obesity and overweight
  • MASH, the inflamed form of fatty liver disease
  • Heart risk in people with obesity
  • Liver fat and liver scarring

Key studies

Status (November 2026)

Investigational; not approved anywhere. In April 2026 Boehringer Ingelheim reported SYNCHRONIZE-1, its first phase 3 obesity trial: up to 16.6% average weight loss at 76 weeks, against 3.2% on placebo.

Quality Standards

  • Form: freeze-dried powder in sealed vials
  • Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
  • Batch report: goes up on /lab-results once testing of the first batch is complete

Related research

For research purposes only. Not for human consumption or therapeutic use.

Research Context for Survodutide

Metabolic and Weight Loss Research Context

This compound sits in the incretin and metabolic peptide class, where research focuses on appetite regulation, glucose handling, energy expenditure, and the complex signaling network that connects gut, pancreas, liver, and hypothalamus. Research protocols in this category typically involve dose escalation, tolerability mapping, and long-duration observation of metabolic endpoints.

Survodutide ships as a lyophilized research reagent through the LyzeLabs™ catalog in the GLP-1 and metabolic category, with 3 variant options sized to different research protocols. Verified LyzeLabs compounds publish their full HPLC chromatogram and mass spectrometry confirmation for each batch on the LyzeLabs lab results page; this compound's analytical data is published there as it completes verification.

Other Compounds in the GLP-1 and metabolic Category

Frequently Asked Questions

What is survodutide?

A once-weekly peptide that activates the GLP-1 and glucagon receptors, developed by Boehringer Ingelheim under the code BI 456906.

Is survodutide approved?

No. As of November 2026 it is in phase 3 trials and not approved anywhere. The survodutide sold here is research material for laboratory use only.

Survodutide vs mazdutide: what is the difference?

Both act on the GLP-1 and glucagon receptors. Survodutide comes from Boehringer Ingelheim and is in phase 3 trials. Mazdutide comes from Eli Lilly and Innovent and is approved in China.

Survodutide vs retatrutide: what is the difference?

Survodutide acts on GLP-1 and glucagon receptors. Retatrutide adds a third, GIP. Survodutide comes from Boehringer Ingelheim, retatrutide from Eli Lilly.

What comes in a survodutide kit?

Ten sealed vials of freeze-dried survodutide, all from one batch, at 5 mg, 10 mg or 15 mg a vial.

How should survodutide be stored?

Keep the sealed vials at -20°C. Once mixed, keep it at 2 to 8°C and use it within 14 days.

How does survodutide ship?

Survodutide ships as a freeze-dried powder in sealed vials, which stays stable at room temperature for the trip. Every order goes out in plain packaging with tracking, and most arrive in 7 to 14 days. Store it in the freezer at -20°C once it arrives.

1 kit

$295